Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C.

Saved in:
Bibliographic Details
Title: Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C.
Authors: Cooke GS; Department of Infectious Disease, Imperial College London, London, W2 1NY, UK.; NIHR Biomedical Research Centre, Imperial College NHS Trust, London, W2 1NY, UK., Pett S; MRC Clinical Trials Unit, University College London Medical School, London, UK.; Mortimer Market Centre, Central and North West London NHS Foundation Trust, London, UK.; Institute of Global Health, University College London Medical School, London, UK., McCabe L; MRC Clinical Trials Unit, University College London Medical School, London, UK., Jones C; Department of Infectious Disease, Imperial College London, London, W2 1NY, UK.; NIHR Biomedical Research Centre, Imperial College NHS Trust, London, W2 1NY, UK., Gilson R; Mortimer Market Centre, Central and North West London NHS Foundation Trust, London, UK.; Institute of Global Health, University College London Medical School, London, UK., Verma S; Hepatology, Brighton and Sussex Medical School, Brighton, UK., Ryder SD; Hepatology, Nottingham University Hospitals NHS Trust, Nottingham, UK., Collier JD; Hepatology, John Radcliffe Hospital, Oxford, UK., Barclay ST; Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK., Ala A; Clinical and Experimental Medicine, University of Surrey, Guilford, UK., Bhagani S; Infectious Diseases, Royal Free Hampstead NHS Trust Hospital, London, UK., Nelson M; HIV Medicine, Chelsea & Westminster NHS Trust, London, UK., Ch'Ng C; Swansea Bay University Health Board, Swansea, UK., Stone B; Infectious Diseases, Sheffield Teaching Hospitals Nhs Foundation Trust, Sheffield, UK., Wiselka M; Infectious Diseases, University Hospitals of Leicester NHS Trust, Leicester, UK., Forton D; Hepatology, St George's Hospital, London, London, UK., McPherson S; Heaptology, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle, UK., Halford R; Hepatitis C Trust, London, UK., Nguyen D; Peter Medawar Buildling for Pathogen Research, Oxford, UK., Smith D; Peter Medawar Buildling for Pathogen Research, Oxford, UK., Ansari A; Peter Medawar Buildling for Pathogen Research, Oxford, UK., Dennis E; MRC Clinical Trials Unit, University College London Medical School, London, UK., Hudson F; MRC Clinical Trials Unit, University College London Medical School, London, UK., Barnes EJ; Peter Medawar Buildling for Pathogen Research, Oxford, UK.; Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK., Walker AS; MRC Clinical Trials Unit, University College London Medical School, London, UK.
Source: Wellcome open research [Wellcome Open Res] 2021 Jul 29; Vol. 6, pp. 93. Date of Electronic Publication: 2021 Jul 29 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Wellcome Trust Country of Publication: England NLM ID: 101696457 Publication Model: eCollection Cited Medium: Print ISSN: 2398-502X (Print) Linking ISSN: 2398502X NLM ISO Abbreviation: Wellcome Open Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2398-502X
DOI:10.12688/wellcomeopenres.16594.2